Cargando…
Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies
Autor principal: | Qiu Hua Chen, Autumn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266374/ https://www.ncbi.nlm.nih.gov/pubmed/35813526 http://dx.doi.org/10.1177/17151635221102415 |
Ejemplares similares
-
The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study
por: Choremis, Beatrice, et al.
Publicado: (2019) -
Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
por: Daskalakis, George, et al.
Publicado: (2021) -
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019) -
Take-home Naloxone at Opioid Treatment Programs: A Lifesaver
por: Katzman, Joanna G., et al.
Publicado: (2022) -
Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013)